ARCHIVES

NCI Advisory Group, Other Cancer Meeting

This article is from The Cancer Letter archive.

Vol. 04 No. 21 | May 26, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

ASCO Honors Eight With Special Awards

May 24, 2002

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000